An indoor cannabis grow, operated by a licensed Washington cannabis cultivator.

3rd Annual Cannabis Collaborative Conference Coming to PDX Feb. 15-16

The third annual Cannabis Collaborative Conference (CCC) is coming to Portland, Oregon next week, February 15-16.

CCC PDX is really amping things up this year at the Portland Metropolitan Exposition Center (Portland Expo Center). Historically, the two-day cannabis conference and networking event has brought out the largest crowds you can find in Oregon for B2B cannabis events.

George Zimmer, the founder and former CEO of Men’s Warehouse, is slated to give this year’s keynote address.

Other keynote speakers include Cy Scott, founder and CEO of Headset; Steph Sherer, executive director of Americans for Safe Access; Aaron Smith, co-founder and executive director of the National Cannabis Industry Association; Amy Margolis, founder of the Oregon Cannabis Association; and Megan Marchetti, co-owner of Oregon’s Finest, one of Portland’s leading dispensaries.

Beyond keynote speakers, there will be panel presentations featuring more than 80 different speakers, all experts in their respective cannabis business, cultivation, medicine, and/or cultural niches. Additionally, event organizers anticipate more than 130 different exhibitors — including leading brands from Oregon, the West coast, and around the country — to populate the trade show portion of the conference.

With Oregon’s adult-use and medical marijuana markets well into their youth, this year’s event puts a special focus on connecting the industry’s many entrepreneurs and investors.

“First and foremost, the CCC is a business-to-business conference geared to both cannabis entrepreneurs and investors,” said CCC producer Mary Lou Burton. “This year we’ve beefed up this aspect with an enhanced Investor Forum and an app that helps start-ups communicate with investors quickly and easily.”

This year’s Investor Summit, an add-on to compliment the conference’s robust speaker program, comes with two tracks for attendees to follow. One track is for investors hoping to find the next big idea or startup opportunity, and the other track is for entrepreneurs in search of funding and expert advice. According to Burton, the “Pitch Portal” for entrepreneurs is to be filled out online prior to the show, for the perusal of attending investors.

“We set up the ‘Pitch Portal’ for businesses to fill out a form with an elevator pitch overview of their business that will be sent to 15-20 investors who can make appointments to meet with the business in our ‘Match-making lounge’,” Burton said.

Registration for the conference is open and ongoing. Tickets cost $149 for a single day or $249 for both days. Tickets to the Investor Summit are sold separately and go for $89, while attending the event’s Career Readiness Workshop costs $50. All ticket purchases can be made through CCC-con.com.

Also, if you are planning to attend CCC 2017, keep an eye out for Ganjapreneur while you’re there — we are excited to be attending and providing event coverage, so give a wave or come say hello!

End


A dispensary worker at Chalice Farms in Portland, OR stuffs pre-rolled joints in the back room.

Poll: RI Voters Favor Adult-Use Cannabis Market

According to a Public Policy Polling survey, Rhode Islanders are slightly more in favor of legalizing adult-use cannabis today than they were in 2015; finding 59 percent of voters support a regulated cannabis industry compared to 57 percent two years ago. About one in three, 36 percent, said they were opposed in the poll taken between January 27 and January 29, WPRI reports.

The survey comes as Democratic lawmakers Rep. Scott Slater and Sen. Joshua Miller, chairman of the Senate Health and Human Services Committee, introduced legislation to enact an adult-use market. Their proposal would allow adults 21 and older to possess 1 ounce of flower, grow one mature cannabis plant, providing for retails sales taxed 23 percent in addition to the 7 percent state sales tax.

“Our job is to represent the people of this state, and their position on this issue is pretty clear,” Slater said in a Rhode Island Public Radio interview.

The poll was commissioned by Regulate Rhode Island. A 2016 survey by Brown University found 55 percent of registered voters supported legalizing cannabis for adult use.

“The results of this poll confirm that our constituents want us to follow the same path as Massachusetts and Maine,” Miller said in the report.

End


The Mendocino Hotel in Mendocino, California.

Lawsuit Contends that Mendocino County Cannabis-Tax was Improperly Approved

Advocates in Mendocino County, California have filed a lawsuit against officials over the cannabis tax levied on the cannabis industry in a voter-approved initiative, the Press Democrat reports. The plaintiffs claim that the measure – which enacted a 2.5 percent to 10 percent tax on growers and flat $2,500 rate a year on other operators – was not properly approved, and should have been proposed as a special tax which would have required two-thirds vote to pass. The measure passed by 64 percent last November.

The proposal, Measure AI, was joined on the ballot by a non-binding advisory measure that showed voters wanted the cannabis tax money used for cannabis industry code enforcement, road repair, and police, fire and emergency medical services. Lawrence Rosin, the plaintiffs’ attorney, and himself a grower, argues that while the description includes county services it’s too specific as a general tax.

The case mirrors another in Ukiah, where a voter-approved cannabis sales tax measure is being challenged in court by the Howard Jarvis Taxpayers Association. In that case, the association contends that these so-called double measures are commonly used to circumvent voting requirements for special taxes.

Mendocino County Supervisor John McCowen indicated that past challenges against double measures have failed and that the industry didn’t pay taxes for decades.

End


A wide-brimmed cannabis leaf.

UC Davis Study Finds Some Northern California MMJ Tainted with Fungi, Mold

A University of California Davis study discovered bacteria and mold on medical cannabis samples from 20 Northern California dispensaries, according to a Sacramento Bee report. The study results were published in the journal of Clinical Microbiology and Infection.

Dr. George Thompson, UC Davis Department of Microbiology and Immunology, warned against patients with weakened immune systems from smoking, vaping or inhaling aerosolized cannabis, but indicated “for the vast majority of cannabis users, this is not of great concern.” He said that those with weakened immune systems are advised to avoid unwashed produce and cut flowers because they might contain potentially harmful mold, bacteria, and fungi and believes cannabis should be added to that list.

“…It’s a big oversight in our opinion,” Thompson said in the report. “It’s basically, dead vegetative material and always covered in fungi.”

The study was conducted after two UC Davis patients died from lung infections believed to be caused by tainted cannabis, however that cannot be confirmed without samples of the products they were using before they fell ill. Dr. Joseph Tuscano, a cancer specialist at UC Davis, called for the study after several leukemia and lymphoma cancer patients developed rare, severe lung infections.

The cannabis was tested by Steep Hill Laboratories in Berkeley and all of the samples reportedly tested positive for bacteria and fungi, some related to severe lung infections.

Thompson said that cannabis edibles might be an alternative to smoking or vaping cannabis for those at risk.

“I give that advice with a caveat: We don’t know it’s safer, we think it probably is,” he said.

End


The flag of New Zealand, where health officials have eased medical cannabis restrictions.

New Zealand Health Officials Change MMJ Rules to Ease Access

Medical cannabis laws have been loosened in New Zealand as patients will no longer need to gain approval from the Minister of Health, according to a report from Stuff. Instead of patients having to bring their case all the way to the top, the Ministry of Health, as an agency, can sign-off on all applications.

Associate Health Minister Peter Dunne announced that the new rule takes effect immediately. The health ministry already had the power to approve a specialist’s application to provide Sativex, a cannabis-derived pharmaceutical drug. Last year, the Ministry of Health announced that it was no longer necessary for clinicians to file an application with the federal agency when prescribing Sativex to patients with multiple sclerosis and Dunne is considering allowing the same for six more conditions.

“As I stated in my delegation letter to the director-general, when applications first began to be received it was my view that the final decision appropriately lay at ministerial level, rather than exposing officials to risk, given the complicated and contentious nature of the issue – that is to say the buck stopped with me,” Dunne said in the report.

Julie Anne Genter, health spokesperson for the Green Party, who has led the push for medical cannabis access in New Zealand, said that while the decision removes “one hoop” patients have to jump through to access medical cannabis, “there are many more that need to go.”

“With the advice and support of their doctor, New Zealanders should be able to access medical cannabis as easily and as cheaply as they do any other prescription drug – the announcement today doesn’t allow that to happen,” she said.

The Ministry of Health has been reviewing potential changes to the nation’s medical cannabis laws for over a year.

End


A young hemp crop planted legally in the U.S. under the 2014 Congressional Farm Bill.

Hemp CBD Companies Should Worry About FDA, Not DEA, Intervention

It’s been nearly two months since mainstream media outlets and several cannabis publications published headlines claiming that the Drug Enforcement Administration (DEA) was rescheduling cannabidiol (CBD) into a Schedule 1 substance and that some serious, Drug War-era crackdowns were coming.

We reported then, and stand by our coverage, that this is not the case. The DEA did not target the hemp CBD industry but instead created a new tracking code for the agency to categorize cannabis concentrates separately from flower, plants, and other products. Confusing verbiage in the rule change, which took effect January 13, led to the widely-reported misunderstanding; however, the fact remains that CBD from cannabis has always been considered a Schedule 1 substance under the Controlled Substances Act.

It wasn’t until the 2014 Congressional Farm Bill that industrial hemp (which, under federal law, must contain less than 0.3 percent THC) was legalized. Lawmakers accomplished this not by removing hemp or CBD from the Controlled Substances Act, but by prohibiting the Department of Justice from spending funds on prosecuting state-legal hemp operations, which laid the groundwork for the CBD hemp market. Only Congress — not the DEA — has the power to undo that act.

Attorney Craig Brand, founder of the international firm Ganja Law, is a 26-year veteran of narcotics case law. A recent memo from Brand’s firm, published in an email to their followers by Folium Biosciences, a client of Ganja Law, echoed the sentiments of legal experts from around the country — that the threat of a DEA crackdown on hemp CBD had been blown wildly out of proportion.

In a recent interview with Ganjapreneur, Brand said that, instead of worrying about the DEA, hemp entrepreneurs should be more concerned about actions taken by the Food and Drug Administration (FDA). “I don’t necessarily see the DEA as the villain of the [CBD] industry,” Brand said. “The bigger danger is, when it does become legal, what is the FDA going to do with it?”

The real dangers facing hemp-derived CBD

According to Brand, there are two major issues that the FDA will likely look to as they regulate hemp-derived CBD. These are the irresponsible “bad apples” who are currently participating in the industry, and the eventuality of a corporate takeover by everyone’s least-favorite agricultural monstrosity, Monsanto (or a similar corporate powerhouse).

Though hemp-based CBD is normally beyond the DEA’s scope of influence, rule-breaking individuals have gained the agency’s attention by producing, selling, and purchasing “hemp,” “hemp oils,” or extracts which contain an illegal amount of THC. Oftentimes, these are simply cases of bad luck or poor foresight; other times, however, there are troublemakers who are purposefully trying to circumvent federal drug laws.

Sadly, these instances support the unfortunate perception that CBD entrepreneurs are would-be cannabis pushers. This could ultimately worsen the industry’s image and lead to even harsher restrictions. “The industry has to regulate itself,” Brand said. “If you do things right, if you self-police, you shouldn’t have to look over your shoulder or require government intervention.”

Brand and the Ganja Law team have created legal policies, compliance protocols, and safeguards for the international cannabis and hemp law practice — however, concerns about a corporate takeover of the CBD marketplace don’t come with a solution as simple as just obeying the rules.

Instead, Brand expects regulators to, “let everybody who has fought so hard for legalization finish the fight, and then Monsanto — or companies like Monsanto — will create their own strains, which will be ushered through by the FDA.” Brand says that he and his team have been preparing for this fight for some time.

Big Pharma has undoubtedly been eyeing cannabinoid-based medicines throughout their recent, formative years, and Brand argues that both the hemp and cannabis industries should be extra wary of industry developments involving Big Pharma when federal prohibition finally crumbles. “If we don’t solidify the rules and players now, be careful what you wish for should cannabis and hemp gain federal approval and we haven’t sidelined those big businesses that have been quietly lurking in the wind.”

“Monsanto is already growing various strains of hemp,” he said. “You don’t have to be a rocket scientist to figure out their next move and our forthcoming fight to remain on the playing field.”

End


Fruits of a licensed cannabis grow in Washington state.

DC Residents Invited to Compete for Best Home-Grown Cannabis

On February 11th, at Red Rocks on H street NE, from 1pm-6pm, home-growers will be able to get their buds tested, learn about safely making edibles at home, meet and talk to medical dispensary owners and growers, and learn about the cannabis networking groups and resources available to District residents.

For the first time, home-growers in the District can get their cannabis tested ON SITE with IMMEDIATE results about THC & CBD potency, ratio of THC to CBD, and moisture content. The Steep Hill Express is internationally recognized as being within 1% of the accuracy of a High-Pressure Liquid Chromatograph (HPLC), analytical chemistry’s gold standard. It is an essential part of many cultivators’ & processors’ businesses to assess, in real time, how their flower is progressing.

Not only will growers be able to get their buds tested, but will learn about safely making edibles at home, meet and talk to medical dispensary owners and growers, and learn about the cannabis networking groups and resources available to District residents. We’ll have plenty of adult prizes and giveaways: National Cannabis Festival tickets, a local membership to Women Grow‘s D.C chapter, clone giveaways, educational take homes, cold hard cash, and (limited w/ticket purchase) free cocktails.

Because D.C. is STILL a drinking city, after all.

This collaborative educational event will also feature a competition, there will be product and ticket giveaways, take-home information, and cash ($250) prizes for highest THC and highest CBD potency. Winners will be awarded after testing has been completed.

This event will be sponsored by Women Grow, Ganjapreneur, Steep Hill, Dr. Chanda Macias (National Holistic Healing Center), DC Hydro, District Growers, National Cannabis Festival, CannX, and DC Taste Buds.  

Steep Hill opened the first commercial cannabis lab in the United States in 2008, and is starting to create relationships on the East Coast as they expand to Pennsylvania, Maryland, and D.C. They have partnered with local canna-businesses to curate an event that ties all of DC’s legal cannabis happenings together under one roof. The goal of this event is celebrate the legal cannabis community, and to help push the East Coast towards setting the standard for cannabis safety.

Tickets are $20-$45 dollars, and bulk testing packages are available! The tickets will only be sold online, and there is a limited amount of testing slots available. Tickets can be purchased here.

Dr. Andrew Rosenstein, MD is the CEO of Steep Hill Maryland/Pennsylvania/D.C., and a board-certified gastroenterologist who has been practicing for two decades in the Baltimore area.

Founded in California in 2008, Steep Hill Labs, Inc. is a science and technology firm that has become the industry leader in cannabis testing and analytics.  Steep Hill is the largest cannabis lab network in the world. The company pioneered the first medical cannabis potency and microbiological contaminants testing methodology for use in California—the first state to legalize medical cannabis. Recently, the company’ received the first Independent Testing Laboratory (ITL) to receive pre-approval from the Maryland Medical Cannabis Commission (MMCC) to test medical cannabis.

Dr. Chanda Macias, PhD, MBA is the Owner of the National Holistic Healing Center Medical Marijuana Dispensary (NHHC) and Medical Marijuana Consultant in Washington D.C. Additionally, Chanda also serves as the S.T.E.M Director at Howard University. 

NHHC is a patient advocated company dedicated to providing individuals with debilitating medical conditions, and specific illnesses with alternative allopathic medicine.  NHHC provides patient education and support, medical marijuana, and medical marijuana infused products to patients in compliance with the DC Department of Health.

End


The Brooklyn Bridge in New York City.

Adult-Use Bills Filed in New York

Adult-use legalization measures have been introduced in both houses of New York’s legislature, which would set up a taxed and regulated system allowing adults aged 18 and older to possess, and adults 21 and older to purchase, cannabis in the state. The Senate version, S.3040, is sponsored by Democrat Sen. Liz Krueger, while the House version, A.3506, is sponsored by Democrat Crystal Peoples-Stokes.

The measure would allow personal possession up to 2 ounces of flower and up to 8 grams of concentrates. It would permit adults to grow up to three mature plants in their home providing for six plants total and allow retail locations to acquire an on-site consumption license if approved by the local government.

Legal sales would be tagged with a 15 percent excise tax, cultivators would be charged $35 per ounce of flower and $10 per ounce of leaves upon transfer, and $5 on the sale of immature plants. Localities could also impose their own taxes. Under the measure, 15 percent of tax revenues would be earmarked for law enforcement and drug rehabilitation programs. Additionally, the proposal calls for “ordinary and necessary expenses” deductible by licensed businesses for New York State tax purposes.

The measure has been referred to the Finance Committee in the Senate, and the Codes Committee in the Assembly.

End


A judge's gavel on their courtroom desk.

DEA Violating Court Orders by Regulating Hemp

The Hemp Industry Association has filed a lawsuit against the DEA seeking to hold the agency in contempt of court for failing to adhere to a previous Court of Appeals decision that prevents the law enforcement agency from regulating hemp-derived food products as Schedule I substances, according to a press release from the HIA.

“Thirteen years ago DEA was told in no uncertain terms by the U.S. Court of Appeals that Congress had made its intent clear: DEA has no power to regulate hemp seed and oil, and the hemp food and beverage products made from them,” Joe Sandler, lead council for the industry association, said in a statement. “It is disappointing that the industry has to revisit the issue, and take this step to compel DEA to obey the law.”

In 2004, the Ninth District Court of Appeals ruled against the DEA, concluding that they had not only violated the Administrative Procedure Act by issuing the hemp rule without notice and comment, but they had also violated the Controlled Substances Act by designating hemp as “marijuana.”

“The Court further found that the ‘non-psychoactive hemp in Appellants’ products was derived from the ‘mature’ stalks or is ‘oil and cake made from the seeds’ of the Cannabis plant, and therefore fits within the plainly stated exception to the CSA definition of marijuana,” the plaintiffs’ motion says. “The Court determined that ‘the DEA’s action is not a mere clarification of its THC regulations; it improperly renders naturally-occurring non-psychoactive hemp illegal for the first time.’”

According to court documents, the HIA argues that the DEA has no intention of cooperating with the court’s decision and “has simply refused to accept the Court’s ruling over a decade ago as governing law.”

The HIA filed a separate lawsuit on January 13, 2017 against the DEA after they announced the creation of a new code number for cannabis extracts, which some have interpreted to include hemp oils.

End


A farm's barn located in Arnott, Wisconsin.

MMJ Bills Introduced in Wisconsin

Democrats in Wisconsin have introduced two bills that would legalize medical cannabis in the state, but will face opposition from a Republican-dominated Legislature and Gov. Scott Walker, according to a Capital Times report. The first piece would allow patients with qualifying conditions to access cannabis products; the second would put the issue to voters in a nonbinding voter referendum.

The bill cosponsors, Sen. Jon Erpenbach and Rep. Chris Taylor, say that if measure legalizing medical cannabis use doesn’t gain legislative traction, lawmakers could support asking voters to weigh in on the issue.

“This will lead to law-abiding citizens who have chronic diseases and health issues we can’t even begin to imagine, to put them in a situation where they don’t have to break the law anymore,” Erpenbach said in the report.

Supporters are hoping that lawmakers could get behind the idea amid a national opioid crisis. The governor called for a legislative special session earlier this year, directing legislators to develop proposals aimed at combatting heroin and opioid abuse.

Two studies have shown that medical cannabis has promise as a way to reduce opioid use; a 2016 University of Michigan study found a 64 percent reduction in opioid painkiller use. A 2014 study published in the Journal of the American Medical Association showed a 25 percent reduction in opioid-related deaths in states with medical cannabis programs compared to those without.

End


An individual with their hands handcuffed behind their back.

Two Former Vireo Officials Charged with Illegally Transporting MMJ from Minnesota to New York

Two former Vireo Health officials face felony charges over allegations that they illegally transported medical cannabis oils from their Minnesota to New York facilities, the Journal News reports. Authorities in Minnesota allege that ex-Chief Medical Officer Dr. Laura Bultman, and former Chief Security Officer Ronald Owens used the company’s armored vehicle to drive about $500,000 worth of its cannabis oils from Minnesota to New York, trying to meet the January 2016 deadline under New York’s medical cannabis program.

Last spring, authorities were alerted to the scheme by a whistleblower and raided one of the company’s Minnesota’s facilities and investigators seized company records, computers, and paperwork associated with the missing products. According to the report, Bultman’s emails and text messages showed that the company was having trouble manufacturing products in New York and allegedly detailed the plan to illegally fill the shelves with products from their Minnesota operations.

Andrew Mangini, a spokesman for Vireo Health, said the company has cooperated in the investigation and confirmed that both Bultman and Owens were no longer with the company.

“When we became aware of the possibility that one or more individuals may have acted in ways contrary to the laws of the state and to our own policies and procedures, we acted immediately to investigate the allegations, communicate with our regulators and take appropriate action, Mangini said in the report.

Bultman and Owens both face two counts of two counts of intentionally transferring medical cannabis to a person other than allowed under Minnesota state law; if convicted, they face penalties of up to two years imprisonment and a $3,000 fine per charge.

End


Oregon Commission Bars Cannabis-Infused Alcohol, Hemp OK

The Oregon Liquor Control Commission will allow alcohol brewers and distillers to use hemp in their products but have declined to allow the use of THC-rich cannabis in alcohol production, according to an advisory document from the commission released today. The hemp used by brewers must meet the federal standards and the formulas and labeling used by brewers must be approved by the U.S. Alcohol and Tobacco Tax Trade Bureau.

According to the report, brewers are interested in using hemp because it adds flavors similar to hops when used in beer production. The OLCC ruled that while hemp can be used for alcohol production, it considers such cannabis-infused beverages adulterated, which is prohibited by state law.

“Adding marijuana or marijuana items to alcoholic beverages adulterates the product,” the advisory states. “Therefore, unless allowed under the following exception, marijuana-infused alcoholic beverages are prohibited in Oregon.”

The licensee must provide proof that the formulation meets the Trade Bureau standards before hemp-infused beverages are manufactured, imported or sold in Oregon, according to a press release from the commission. All imported raw hemp will be tested each time to ensure it meets the federal standards. The finished products will also be tested for controlled substances.

End


A homegrown cannabis plant in Oregon.

Israeli Government Committee Approves MMJ Export Plan

An Israeli government committee has moved forward plans to allow the exportation of medical cannabis from the country, but it could take months to move through the nation’s parliament, according to a report from Reuters.

The plan was announced in December by an inter-ministerial committee of director generals, comprised of the Ministries of Justice, Finance, Public Security and Health. Israel has positioned itself as a leader in the medical cannabis sector, recently approving 13 medical cannabis studies for federal funding, and a plan to decriminalize the drug nationally found support at a legislative hearing last month. Currently, there are about 23,000 patients registered under the nation’s medical cannabis program, with nine licensed suppliers. According to the Reuters report, the nation’s market is worth $15 to $20 million “at most.”

Saul Kaye, CEO of iCan, a private cannabis research firm in Israel, estimated that there was about $100 million in international investments made in the nation’s cannabis sector in 2016, with about 50 medical cannabis companies active in the industry, ranging from agriculture to delivery devices.

According to a December report from Yediot Ahronot, the exportation of medical cannabis would create thousands of agricultural jobs and be worth $1 billion Israeli New Sheqel (more than $2.6 billion).

End


View looking up from the floor inside of a licensed cannabis grow operation in WA.

GTI Massachusetts Files Dispensary Application in Holyoke

GTI Massachusetts NP Corp., has filed an application to bring Holyoke, Massachusetts its first medical cannabis dispensary, according to a report from MassLive. The plan would see the facility opened on the second floor of a building in a general industry zoning district, of which the first floor is currently occupied by an electronics company.

According to a letter from attorney John J. Ferriter on behalf of GTI Massachusetts, the facility would provide 25 to 30 full-time jobs with benefits, and tax revenues in its first year of operation.

“Why we chose Holyoke? Easy answers. Great access to a quality labor force. Close to our other dispensary location in Amherst,” Kadens said in the report. “Lots of quality and affordable industrial space. A supportive mayor.”

GTI’s Amherst dispensary is not yet open; however the report indicates that it is expected to start operating sometime this year.

According to the paperwork filed by Ferriter on behalf of GTI Massachusetts, the proposal furthers the purpose of Holyoke’s Urban Renewal Plan, as the 43,000 square foot location is “currently vacant and underutilized.”

“Such a development will both provide increased tax revenue to the city and municipal fees to city departments, as well as a conscientious and attentive community partner,” Ferriter wrote in the letter.

Holyoke Mayor Alex Morse has expressed strong support for his city hosting the legal cannabis industry and is encouraging potential growers to consider setting up shop in the city’s vacant textile mills which take up more than 1.5 million square feet of space.

End


Recreational cannabis plants inside of a Bellingham, Washington grow facility.

Federal House Bill Would Reschedule Cannabis, Re-Define Marijuana to Exclude CBD

Republican Virginia Rep. Griffith H. Morgan has introduced legislation to reschedule cannabis under the federal Controlled Substances Act, and exclude cannabidiol from the definition of marijuana.

According to the bill text, CBD would be defined exclusively as cannabis not containing more than 0.3 percent THC “on a dry weight basis.” The proposal does not include any indication or direct order pertaining to how cannabis would be rescheduled; instead it leaves that responsibility to the Secretary of Health and Human Services, and National Academy of Sciences’ Institute of Medicine, who would issue a recommendation to the Administrator of the Drug Enforcement Agency.

President Donald Trump has tabbed Georgia Republican Rep. Tom Price as his HHS secretary – a strong medical cannabis opponent who voted six times against amendments preventing Justice Department interference from state-approved medical cannabis laws, and three times against allowing Veterans Affairs doctors to recommend the drug, according to a New York Times report.

If Price were confirmed for the post, he would likely be the HHS Secretary if the law were to pass – which requires the recommendation to the DEA no later than180 days after the law’s enactment.

In a blog post, NORML said that while rescheduling cannabis “will not end federal prohibition” it would “bring an end to the federal government’s longstanding intellectual dishonesty that marijuana ‘lacks accepted medical use.’

“It would also likely permit banks and other financial institutions to work with state-compliant marijuana-related businesses, and permit employers in the cannabis industry to take tax deductions similar to those enjoyed by other businesses,” the post reads. “Rescheduling would also likely bring some level of relief to federal employees subject to random workplace drug testing for off-the-job cannabis consumption.”

The bill was referred to both the House Judiciary, and Energy and Commerce committees.

End


Alabama Sen. Jeff Sessions takes the stage during a Trump rally in 2016.

Sessions AG Nomination Heads to GOP-Led Senate

The Senate Judiciary Committee has approved the nomination of Alabama Sen. Jeff Sessions as Attorney General in a straight partly-line vote, the New York Times reports. Sessions’ nomination moves now to the Republican-controlled Senate following the 11-9 committee vote.

There is little reason to believe that Sessions will not be confirmed by the Senate next week.

So far, Sessions’ views on how he will handle the legal cannabis industry are unclear. He was vague on the topic during his testimony in front of the Judiciary Committee, saying that if prohibition at the federal level was “not desired any longer…Congress should pass a law and change the rule.”

His written testimony offered little additional insight.

In his written responses, Sessions admitted that he was “generally familiar” with the Cole memo – which instructed federal agencies to not interfere with the legal cannabis industry – but has not studied medical cannabis regulations “in depth.” In a response to Sen. Dick Durbin, Sessions called cannabis a “dangerous drug” and refused to say explicitly that he would not make arrests under federal law in legal states.

“Whether an arrest and investigation of an individual who may be violating the law is appropriate is a determination made in individual cases based on the sometimes unique circumstances surrounding those cases, as well as the resources available at the time,” he wrote.

End


Inside a cannabis cultivation site in Washington state,

Two California Universities to Offer Cannabis-Related Courses

The University of California at Davis and Sonoma State University are set to begin offering cannabis-related college courses this spring. The higher education institutions represent the second and third in the state to offer cannabis-centric courses after the City College of San Francisco announced they had plans to offer their own course last month.

According to a Davis Enterprise report, the UC Davis “Physiology of Cannabis” undergraduate course is designed for biological sciences students and will cover therapeutic values, physiological effects in multiple systems, the biology of cannabis and cannabinoids, and the current and potential medical targets for cannabis and its effectiveness.

According to UC Davis School of Medicine Associate Professor Yu-Fung Lin, who is teaching the course, it is the first of its kind offered, at not just UC Davis, but “likely within the entire U.S. system.”

“This course is one of the few taught on an American college campus with a dedicated theme on the biology, physiology and medicinal effects of cannabis and cannabinoids,” she said in the report.

The Sonoma State University course is considerably less rigorous and aimed solely at current health care professionals. “Medical Cannabis: a Clinical Focus” is a one-day program intended as a workforce development course. It will cover some of the history of cannabis, dosing and administration, legal consequences, and an introduction to cannabinoids and terpenes, the North Bay Business Journal reports.

Robert Eyler, dean for the School of Extended and International Education, indicated that the school is “nowhere close” to offering a cannabis-related major. However, there are plans to offer another three-hour cannabis-related course in March.

“We have no intention of offering courses about entrepreneurship or the business side of it,” he said.

The SSU program is being conducted in partnership with the United Patients Group.

End


The main street of Alaska's capital city, Juneau.

Alaska Officials Vote Against Public-Use at Cannabis Retail Stores

The Alaska Marijuana Control Board has voted 3-2 not to allow cannabis consumption at retail stores, according to a report from the Associated Press. The measure would have made Alaska the first state in the nation to approve consumption at legal cannabis shops.

Board member Mark Springer said he rejected the measure partly over concerns about how President Donald Trump’s administration will handle the legal cannabis industry.

“We don’t want to be waving a red flag in front of federal law enforcement, at least not now,” Springer said in the report.

Cary Carrigan, Alaska Marijuana Industry Association executive director, thinks that allowing cannabis-use at retail stores will happen eventually because one of the driving forces behind the voter-backed measure was allowing tourists to consume cannabis, especially cruise ships. Last year, Alaska had more than 2 million tourists – just over half arrived on cruise ships.

“What are they going to do?” Carrigan asked. “There’s going to be 500 people standing on the docks, smoking a joint.”

Most of Alaska’s tourists visit during the summer months, and tourism – a $1.9 billion industry in Alaska from 2014-2015 – could increase this year as retail stores begin opening across the state, but presently there is no place for them to legally consume the drug.

End


Cannabis investments have turned the industry into one of the most explosive and fastest-growing markets in the world.

Salveo Capital Invests in Ancillary Companies Headset & Front Range Biosciences

Chicago-based Salveo Capital has made its first round of cannabis-related investments, according to a recent Crain’s report. Two ancillary companies — Headset and Front Range Biosciences — are set to receive large infusions of cash from Salveo Capital, an investment firm founded in 2015 by lawyer Alex Thiersch.

According to March media reports, Salveo’s initial goal was to raise $25 million to use for cannabis-specific investments, but Salveo managing partner Jeff Howard declined to comment on the total amount Salveo has raised. And though the firm’s first two investments went to companies ancillary to the legalized cannabis industry, Howard indicated in the report that Salveo will consider future investments in “touch-the-plant” companies.

Headset is a Seattle-based cannabis analytics firm that currently has two offerings: market research data that tracks the performance of popular brands and products in the industry; and software that connects the different point of sale systems used by retailers and dispensaries, keeps track of their inventory, and monitors in-house sales trends.

Between Salveo’s investment and further injections by Hypur Ventures and Poseidon Asset Management, Headset has reportedly raised $2.5 million in investments. According to Headset’s CEO and co-founder Cy Scott, the new funds from Salveo will go towards developing the company’s third product offering.

Front Range Biosciences is a Lafayette, Colorado-based cannabis biotechnology company that develops technology for producing healthier cannabis strains; their goal is to prevent diseased cannabis crops, which should ultimately reduce legal growers’ reliance on potentially dangerous pesticides. The company plans to use Salveo’s investment to purchase new equipment and hire more staff, though Front Range’s co-founder and CEO Jon Vaught has said that the company is in talks to receive more funds from additional investors.

In total, Salveo has announced plans to fund as many as 15 startups in the cannabis sector, whose focuses are likely to include cannabis finance, agriculture, software, and more.

End


The state flag of Florida on a windy, blue-skied day.

Florida State Sen. Introduces MMJ Overhaul

Florida state Sen. Jeff Brandes has introduced legislation that would totally reform the state’s medical marijuana program, according to a Sunshine State News report. The “Florida Medical Marijuana Act” would increase the number of medical marijuana treatment centers allowed in the state and create four new types of licenses for those businesses.

“The laws on the books today promote a state-sanctioned cartel system that limits competition, inhibits access, and results in higher prices for patients,” Brandes, a Republican, said in the report. “Florida should focus on what is best for patients.”

During last November’s election, voters passed an initiative that provided for a more comprehensive medical cannabis system, expanding patient access and available products. Lawmakers and the Florida Department of Health have up to nine months to develop new industry regulations and six months to amend the current laws.

Under Brandes’ plan, dispensaries would have cultivation, transportation, processing, and retail licenses, and would be able to hold a combination of those licenses. Current law permits one retail license per 25,000 residents for each county.

Ben Pollara, campaign manager for United for Care, said the proposal “does an excellent job of establishing a comprehensive tightly regulated” medical cannabis program in the state.

“The two most essential pieces of implementation are maintaining the primacy of the doctor-patient relationship, and expanding the marketplace to serve patient access. SB 614 does both in a well-regulated, well thought out manner,” he said.

Additionally, the measure would allow the University of Florida to conduct research on the use of cannabis as a treatment for animals with seizure disorders “or other life-limiting illnesses,” barring state funds from being used for that purpose.

End


Snow-covered downtown Holyoke, Massachusetts.

Holyoke, Mass. Mayor is Welcoming Cannabis Industry

If the mayor of Holyoke, Massachusetts has his way, the city will reinvent itself as a cannabis cultivation hot spot in New England, according to a Telegraph report. Mayor Alex Morse, 27, is encouraging growers to move into the vacant textile mills which take up 1.5 million square feet of space in the town of 40,000, of which nearly a third live below the poverty line.

“One cultivator using 40,000 square feet would create 50 jobs,” he said in the report. “We could be talking about hundreds of jobs for residents of our community.”

In addition to job creation, Morse believes that a thriving cannabis industry would be an economic and tourism boon for the town.

“People already come up in the fall to enjoy the foliage. Adding legal cannabis will do a lot to encourage tourism,” he said.

However, City Council President Kevin Jordan stands opposed to the plan, saying they “don’t want to be known as the marijuana Mecca of Massachusetts.”

Last month, state lawmakers passed legislation delaying the opening of retail dispensaries from January to July 2018, and officials are still developing the rules for the recreational industry. But Morse indicated that negotiations are already underway with at least one producer.

End


A sea of green inside the grow facility of a licensed Washington state cultivator.

State Cannabis Regulators Often Moving On as Consultants, Lobbyists

Former state cannabis regulators are bringing their expertise to the private sector, forming consulting firms and lobby groups, according to a report from The Hill. Some are advising states and municipalities on how to implement new laws, and others are pushing their former colleagues for industry reforms.

Andrew Freedman, who served as the director of marijuana coordination in Colorado, and Lewis Koski, former head of the state Marijuana Enforcement Division, formed a consulting firm to advise governments on how to set up a regulatory system.

“We’re the only ones to have stood this up before,” Freedman, said in the report. “There’s a real opportunity to come in and show lessons learned quickly.”

Earlier this month, Laura Harris, who preceded Koski, took a job as the director of the Colorado Chamber of Commerce. Former overseer of the Minnesota Office of Medical Cannabis, Manny Munson-Regala, created his own firm, Root Cause Consulting. John O’Brien resigned from his post at New Jersey’s medical cannabis program for a job as chief compliance officer for a New York cannabis company.

Under Minnesota law, regulators are required to take a year off before returning to the industry. Munson-Regala said the requirement is not unlike other sectors, such as insurance.

“Embedded in that one-year cooling off period was an understanding that regulators are in a good position to help folks who are being regulated, in part because they understand what it takes to be compliant,” he said.

Aaron Scherb, legislative affairs director for Common Cause, said he supports cooling off periods and would like to see them implemented in more states with legal cannabis programs.

“These individuals are the most familiar with the rules and regulations of a particular industry, and their experience means they’re able to exploit loopholes,” he said. “At least some minimal amount of time is appropriate so we can avoid this revolving door problem.”

End


The U.S. Supreme Court in Washington D.C.

Trump’s Supreme Court Nominee Has No Prohibitionist Red Flags

Judge Neil Gorsuch, President Donald Trump’s Supreme Court Nominee, has ruled on just three cannabis-related cases in recent years while serving on the 10th Circuit Court of Appeals in Denver, Colorado, which makes it difficult to determine how he might rule on such cases on the federal bench, according to a Vice report. He is, though, known as a states’ rights advocate which could be good news for the cannabis industry.

In December 2015, Gorsuch ruled against a Colorado dispensary in a case against the Internal Revenue Service; but in his opinion he seemed sympathetic to the business owners, saying that the government has sent “mixed messages…about the distribution of marijuana.” In that case, the dispensary owners sought to use Fifth Amendment protection against self-incrimination, which would have allowed them to keep their business a secret and reduce their tax bill.

“So it is that today prosecutors will almost always overlook federal marijuana distribution crimes in Colorado but the tax man never will,” Gorsuch wrote in that decision. “…the government simultaneously urged the court to take seriously its claim that the petitioners are violating federal criminal law and to discount the possibility that it would enforce federal criminal law.”

In a 2013 case against a police officer who used a taser on suspect who fled trying to avoid being arrested for an illegal grow, Gorsuch wrote the majority opinion. The suspect died due to a heart condition and his parents sued. In his opinion, Gorsuch opined that the although “illegal processing and manufacturing marijuana may not be inherently violent crimes” the use of force was reasonable because the suspect was a felon under state law at that time.

In a 2010 case, the court ruled against a couple accused of selling cannabis illegally who used the Religious Freedom Restoration Act as their defense. In that case, the 10th Circuit ruled that the act didn’t apply to the couple because “their marijuana dealings were motivated by commercial or secular motives rather than sincere religious conviction.”

Alex Kreit, director of Thomas Jefferson School of Law’s Center for Law & Social Justice, said that there was nothing to indicate Gorsuch would be strongly opposed to cannabis legalization.

“There isn’t anything in his record that suggests he is a hardline anti-marijuana, pro-mandatory minimum zealot in the mold of Jeff Sessions — at least not that I’ve seen,” Kreit said in the report. “And there are at least some cases that suggest he’s willing to rule in favor of individual rights and against the government in some criminal justice cases.”

End


Marc Shepard: Preparing for Legalization in New England

Marc Shepard is an active member of NORML, MassCann, and the Patient Advocacy Alliance. He is also co-founder of the New England Cannabis Convention: an extensive and affordable cannabis industry business conference that is returning to Boston this April.

In the following interview, our podcast host TG Branfalt and Marc discuss what can be expected for Massachusetts and Maine (the first states in New England to legalize adult-use cannabis), what is likely to happen to the states’ medical markets as recreational laws come online, how lawmakers and entrepreneurs are preparing for the changes, and more!

Listen to the episode below, or keep scrolling for a full transcript of the interview.

Subscribe to the Ganjapreneur podcast on iTunes, Stitcher, SoundCloud or Google Play.


Listen to the interview:


Read the transcript:

TG Branfalt: Hey, I’m TG Branfalt. You are listening to the Ganjapreneur.com podcast, where we will bring you essential cannabis business news and insights, by speaking with stakeholders, experts, and entrepreneurs, who are focused on normalizing and demystifying the cannabis industry. Since November’s election, the General Election in particular, attention has been paid to California, after all, it is the nation’s most popular state and has led to … The industry is the first state to pass medical cannabis laws, in 1996. New England is quickly making its own mark with two states passing their own adult use measures, a couple of months ago.

Today, I’m joined by Marc Shepard, a member of NORML and MassCann and the Patient Advocacy Alliance. He’s also the co-founder of the New England Cannabis Convention. We’re going to discuss the newly legal eastern states. How are you doing today Marc?

Marc Shepard: Terrific TG, and thank you so much for having me on today.

TG Branfalt: It’s my pleasure, my man. I’d like to kick off our discussion today with Massachusetts. Massachusetts has a medical program, which was pretty new by the time that voters approved the ballot initiative, so let’s start … What’s the status of the medical market, and how might the adult use market impact the current structure?

Marc Shepard: Sure. The brief history in Mass., possession was decriminalized less than one ounce, back in 2008. The medical programs were approved in 2012. The first dispensaries, unfortunately, didn’t open until 2015. You get a taste of the Massachusetts bureaucratic process there. I’m sure that will apply to the new rec market.

The medical program has been up for four years. There’s 35 licenses approved. There are only eight or nine dispensaries active and open. We still have a long way to go just to get enough medicine out to patients. With rec passing now, obviously, the immediate impact, if you’re a patient and you’re having trouble getting to a dispensary, you can now grow up to six plants yourself, possess 10 ounces at home, two ounces in public … You can also be gifted up to an ounce from another person. The first impact of the medical program is just that, patients now who don’t have easy access to a dispensary or a caregiver, have it a little bit easier to try to get medicine now.

TG Branfalt: There’s no indication that the medical market is going to be decimated by the rec initiative?

Marc Shepard: No. I can’t see that. This isn’t a perfect analogy, but I just kind of say, you can get brandy at a liquor store but that’s not medicine. Yeah, there’s cough medicine … Brandy has alcohol in it. It’s kind of the same thing with medical mariajuana. You can go to a rec store and buy cannabis, but honestly, that’s cannabis that’s grown and developed in order to produce a good high for people, whereas medical mariajuana is going to be produced specifically to treat ailments and specific symptoms people have. So the rec market isn’t going to produce the medicine people need for their ailments.

TG Branfalt: So you said that there were 35 licenses, given in Massachusetts, but there are less that 10 dispensaries operating. Do you have any indication when the rest might come online?

Marc Shepard: It’s picking up speed. I think there were more than 90 approved applicants, and they are all going through the process. It’s an arduous, obstacle course of getting through all of the state regulations and then finding a town, and getting all that done. Everybody makes their estimates as to how soon those 35 will open. All I can say, is it’s starting to happen faster and faster. Certainly before there’s recreational stores open, I would guess the number of medical dispensaries will at least double in the next year.

TG Branfalt: Let’s talk about the recreation in Massachusetts. According to Arcview Group and New Frontier Data, they estimate that the state market could be worth one billion by 2020. Much of that figure could be driven by Boston … It’s 200 miles away from New York City. How much of that estimated one billion dollar figure, would you think would be driven by tourism?

Marc Shepard: I’ve been reading a lot about that, and a couple of people have written about how Boston is going to become the capital of cannabis by 2020, for some of the reasons you mentioned. I’m a little bit skeptical of that. I think right now, these estimates are making some assumptions. One, that things are going to progress quickly in the Mass. market, which I don’t think is going to happen, unfortunately. I think it’s going to be much slower than what people think. Also, that’s four years from now. That gives, be it Rhode Island, New York, New Jersey, Pennsylvania … That gives them four years to pass their own recreational ballot. I think those estimates, they’re based on some pretty big assumptions. I think it will be a great market. I think it’ll be a terrific tourist market. I think Cape Cod is a great tourist destination, and obviously Boston can be too. I would just say, in general, my experience with industry forecasts, they’re always wildly positive. I’m not trying to be negative. I just think that’s a little bit high.

TG Branfalt: Now you said several times that you anticipate the roll out of the recreational program being slow. Is this due to the blowback that occurred during the election? During the run up to the election by the governor and the mayor of Boston? Do you think that they’re going to try to stand in the way, or do you think that it’s just going to be a slow process?

Marc Shepard: I think it’s both. I think when you have the mayor of Boston and the governor both openly, fully opposed to this, there’s just so many ways that the sitting government can drag their feet on a process. Also, just with the law itself, it’s pretty vague, and gives states a lot of control on zoning, and on licensing, and how thing are done. So just the normal process of saying, hey, we’ve got to set up a commission. We’re going to set up a brand new control commission and give them nine months to set up rules and regulations. Even out of the gate, you’re talking about a year before a license could even be issued. It’s just going to move slow. It’s going to happen. I think it’s just going to move slower than people think. I don’t think anybody anticipated three years, from the time the medical program was approved till the first dispensaries sold marijuana. If you apply that here, you’re talking 2019 before rec would be sold, which I’m not saying will happen, but that’s what happened with medical.

TG Branfalt: Are there a lot of municipalities seeking to bar a recreational market from existing in their townships?

Marc Shepard: There’s been a decent amount of talk, so far, especially when you’re saying nobody can even apply for a year. The fact that it’s coming up, shows that people are looking at that and are concerned with it. The easiest way for towns to do it, is to set up zoning laws that sort of make it impossible. In my hometown, in North Attleboro, the zoning law for medical dispensary … You have to be separated a certain amount from schools and by churches. When you draw a map of the town, there literally isn’t any space in the town that meets the zoning qualifications. There’s lots of things that people can do to slow things down.

TG Branfalt: What’s the next step in Massachusetts? I know that we’re very early, and that no licenses, even preliminary licenses, have been issued. Where are we now in the process, and what’s next?

Marc Shepard: Sure. Right now, in this first year, there’s 75 available licenses for retail. Each license holder can apply for four different licenses … A retail shop, a product manufacturer, cultivator, and testing facility license. So you theoretically have up to 75 licenses available. In this first year, the only applicants that will be considered for those 75 licenses, will be the 90 people who successfully submitted medical marijuana applications back in 2015, and received a provisional approval. The first 75 will come out of that group. Starting in 2018, the process will be open to everybody. As those licenses are being submitted and applied for, there’s going to be a three person cannabis control commission, that’s going to be named by the state, and they’re actually going to be writing the regulations as they’re getting applications submitted and going though the process.

TG Branfalt: Have any representatives or officials or lawmaker … Have they gone to Colorado, or one of the other legal states, to get an idea of what the regulations might look like?

Marc Shepard: Yeah, there was a group of state reps, and local reps, that did go out to Colorado. They came back with a mixed bag. A lot of their quotes about what they saw, and statistical quotes that they gave to the Boston Globe and the Herald, flew in the face of statistical information from Colorado. You have people coming and saying that there was high crime and social decay, and all these problems that the state itself, in Colorado, claims that’s not true. There was some effort put into that but it seemed there were people out there just looking to sort of validate what they had heard, or what they wanted to say. It’s tough out here. There aren’t many local legislators who think it’s going to be good for them politically, to be at the forefront of this, so everybody is going to kind of … Go along for the ride, but no one is going to lead, because nobody thinks it’s politically advantageous to do so.

TG Branfalt: It’s very interesting that, in a state that has … It wasn’t an overwhelming passage of the law, but that the officials really aren’t behind this at all. It shows the will of the people kind of shining through. Applause to the activists in Massachusetts. We’re going to step away from the show real quick and take a short break. When we come back, we’re going to talk about the other state that legalized adult use cannabis in the northeast, Maine. This is Ganjapreneuer.com podcast. We’ll be right back.

Recorded Voice: Being an entrepreneur comes with a lot of stress. While you are busy developing your business, managing a team of loyal employees, and working to build a sustainable venture, the last thing you should need to worry about are your personal finances. With Latitude Financial Group, you will have the tools you need to manage your finances efficiently and easily, without all the hassle. Latitude Financial Group provides a platform that shows you everything you have, all in one place, and that stays current without time-consuming updates and synchronizations.

You’ll gain access to a free, one-hour consultation and an award winning financial software suite, that will empower you to better visualize and manage your finances. With Latitude, you can form a relationship with an unbiased, fee-based, objective, professional, personal advisor who understands your unique concerns, who listens to your needs, and who has years of experience applying financial solutions to the most complicated of financial scenarios.

Based in Denver, Colorado, the Latitude Financial Group team will work with you in ways that fit your life. Whether you prefer a face to face meeting with an advisor, at one of their 20 metro-Denver area locations, a phone call, or a Skype meeting, they can help you work to achieve your financial goals. So, if your personal or business finances are causing you stress, if you are losing sleep wondering if your financial future is secure in the career path that you’ve chosen, or if you want to work with a financial advisor who is interested in helping you become successful in your business endeavors, give Latitude Financial a call and start being proactive about your financial future today.

Don’t wait. Latitude is offering the first 10 listeners one year of free access to their award winning, software platform. Go to Rollingingrass.com. That’s rollingingrass.com to get Latitude in your financial life. Securities offered through Securities America Inc., the registered, broker, dealer member of FINRA and SIBC. Advisory services offered through Securities America Advisors Inc., an FCC registered investment advisory firm. Scott Cody, Daniel Grote representatives, Latitude Financial Group and Securities America are unaffiliated. Latitude Financial Group and the Securities America companies are unaffiliated.

TG Branfalt: Hey, welcome back to the Ganjapreneur.com podcast. I’m TG Branfalt here with Marc Shepard, member of NORML, MassCann, Patient Advocacy Alliance, and co-founder of The New England Cannabis Convention. We’re here discussing the northeastern states that recently passed adult use cannabis legislation during the general election. We talked about Massachusetts. Let’s move on to Maine. Very similar to how we approached Massachusetts, how will … What’s a brief history of Maine’s medical market, and how do you think that program will jive with the new recreational market?

Marc Shepard: It’s interesting, Maine’s question, really got into the medical program, and tried to protect it a lot more than Mass. It’s a much older program. It started in 1999, passed with a huge majority. There are eight dispensaries open in Maine, which doesn’t sound like a lot, but there’s only a million people in Maine, so it’s the equivalent to maybe six times as many dispensaries, say in Massachusetts. There’s close to 50,000 registered patients and there’s a huge caregiver network in Maine, where people, individuals, can register as caregivers and grow plants, and provide medicine for up to five patients. It’s a huge program that also is an industry. You’ve got 3,000 caregivers making a living off of this. The referendum for rec in Maine, did a lot to protect that. The growing licenses, as they come out … I think it’s 40% of them, are set aside and can only be used by what they call small grows, which wouldn’t be practical for somebody coming from out of state. The laws specifically to have a huge portion of the rec market be awarded to local growers, and more than likely it’ll come from the existing caregivers, those 3,000 caregivers.

TG Branfalt: They were the only state initiative … The city of Denver also did this … to include Cannabis clubs in the legislation. Do you think that this is a good thing? Will it help drive the program, and to what extent?

Marc Shepard: I think it’s a great thing, to be honest with you. There’s a social aspect to cannabis use, just as there’s one for alcohol. It’s sort of legalizing it but making it something that you can only do when you’re hidden in your home, that doesn’t make any sense to me. I’m very excited by that piece of it. It’ll be interesting to see how it plays out in Maine.

TG Branfalt: There’s also been political attempts to thwart the voter initiative. The opponents forced a recount, which was verified as a pass. Governor LePage, has actually said that he wants to get rid of, to quote, “the medical marijuana program.” Similarly to what was done in Washington, which is now forcing patients to pay the 37% excise tax. Who, or what agency would have to implement such changes in Maine, and are activists concerned that LePage will have his way?

Marc Shepard: On the first part, on the recount bit, it was … When you’re trying to get something passed it’s always disappointing, but I think people have to admit, it only passed by 4,000 votes. Any valid question that … is that close … I think a recount is warranted. It was dropped pretty quickly when they saw that there wasn’t enough movement to do anything. I wasn’t really that upset about that.

As far as LePage, as the governor, his lack of information and lack and total refusal to educate himself on the issue, just …. It’s really reprehensible. For anybody again, to think somehow, that recreational marijuana is the same as medical marijuana, it shows that they haven’t made the least amount of effort to look into it. That being said, the medical marijuana program was a people’s referendum. The governor can’t outlaw it. He just doesn’t have anyway to do that. Gay marriage passed in Maine. If the governor is not for that, he can’t overturn it because he doesn’t like it. I think that’s a lot of saber rattling, and that’s just him getting the word out to his constituents, that he’s against it. I don’t see how he can do anything about it.

TG Branfalt: What’s next for Maine? I haven’t really seen any numbers about the projected revenue, such as I did in Massachusetts. Do you have any insights as to what the market might bring in, in Maine?

Marc Shepard: The same survey that you had quoted earlier about Mass. puts Maine at potentially 250 million by 2020. The interesting thing is that Maine is a huge tourist market, not just for New Englanders but also for New York. I think that piece of it, and the fact that there’s the social club aspect, maybe not dollar for dollar bigger than Mass., but I do think it will become a bigger tourist destination than Massachusetts will, just because it’s a great tourist place … The southern coast of Maine.

Right now, where the law stands is the governor, I think 10 days after the recount, to sign off on this, it’s really just a ceremonial thing. It goes into effect in 10 days after the recount ended, whether he signs it or not. It might even be tomorrow that those 10 days are up, and then possession, and growing, and use become legal 30 days after that. We’re looking at, say, the end of January. It’s going to be legal to possess and grow. The commission then has nine months to finalize their regulations. In Maine, it’s actually the Department of Agriculture. They’ll have until October 30, 2017 to finalize the regulations. Then the license application process will open for 90 days for existing dispensaries and care givers. Again, October 30th or so, 2017, is when those applications will start.

TG Branfalt: The legislation is a bit more clear than Massachusetts, in terms of time frame?

Marc Shepard: Yeah, I think so. Mass. Hasn’t even named the three people who are going to make the laws yet.

TG Branfalt: So let’s talk a bit about New England as a whole. Who’s next? Neither Vermont, New Hampshire, Connecticut, nor Rhode Island have voter referendums. Vermont’s tried a couple of times to legalize adult use. It’s failed. They’ve come the closest to a legislature actually legalizing cannabis for adult use. Do you think that Massachusetts and Maine might start a domino effect in New England?

Marc Shepard: I mean, obviously if they’re successful and well run, I think it certainly puts pressure on the other states. I would think, probably, Rhode Island has the biggest stake in that. They were the first state after the Connecticut casinos opened … The indian reservations … Rhode Island was the next state, as they saw they were losing revenue, they opened the first casinos after Connecticut. They’ve got probably the best and biggest, organized, advocacy groups, led by Regulate Rhode Island … Campaigning and lobbying the legislature. I think Rhode Island might be next.

It could happen in Vermont, from what I saw, the failure in the legislative bill was really just about the fact that it was written to benefit retailers. I think that sort of, Vermont attitude, of if we’re going to make anything legal, it’s going to be for people in Vermont to grow and possess this themselves, not to make it just legal to sell. I think it was a case of poorly written legislation that led to the state house to reject it. I think Vermont could pass as soon as the right bill is written.

New Hampshire’s still in it’s baby stages of medical, so I don’t think anything will happen there. I honestly don’t know that much about Connecticut, although they have a functioning medical program, but I haven’t heard much in the way of a thrust from the people for rec. Once these … Maine and Mass. … are up and running, and people are able to either critique them or see the success, I think it does change everything.

TG Branfalt: What might your advice be to potential investors in Maine and Massachusetts?

Marc Shepard: This may run contrary to what a lot of people think, but to me, if you want to get into the business, and you’re not already in it and experienced, look at the ancillary businesses that don’t touch the plant. It’s difficult to navigate, and expensive, and risky, to get into the license lottery. You’ve got to know what you’re doing. You’ve got to be connected. You have to have a lot of cash flow, and you have to be prepared to get shut out, even if you do everything right. If you’re able to capitalize on the ancillary business, be it … There’s millions. There’s lighting, there’s growing. There’s security. There’s transportation. There’s so many ancillary business connected to this industry. I would look at my own skill set and say, what skills are applicable to those ancillary businesses. I would try to establish myself there.

TG Branfalt: We’re going to talk a bit about you bringing some of these businesses together at the New England Cannabis Convention, but first we have to take one more short break. This is the ganjapreneur.com podcast. I’m TG Branfalt.

Recorded Voice: At Ganjapreneur, we have heard from dozens of cannabis business owners, who have encountered the issue of canna-bias, which is when a mainstream business, whether a landlord, bank, or some other provider of vital business services, refuses to do business with them simply because of their association with cannabis. We have even heard stories of businesses being unable to provide health and life insurance for their employees because the insurance providers were too afraid to work with them We believe that this fear is totally unreasonable, and that cannabis business owners deserve access to the same services and resources that other businesses are afforded. They should be able to hire consultation to help them follow the letter of the law in their business endeavors, and that they should be able to provide employee benefits, without needing to compromise on the quality of coverage that they can offer.

This is why we created the Ganjapreneur.com business service directory, a resource for cannabis professionals to find and connect with service providers who are cannabis-friendly and who are actively seeking cannabis industry clients. If you are considering hiring a business consultant, lawyer, accountant, web designer, or any ancillary service for your business, go to ganjapreneur.com/businesses, to browse hundreds of agencies, firms, and organizations who support cannabis legalization and who want to help you grow your business. With so many options to choose from in each service category, you will be able to browse company profiles and do research on multiple companies in advance so you can find the provider who is the best fit for your particular need.

Our business service directory is intended to be a useful and well-maintained resource, which is why we individually vet each listing that is submitted. If you are a business service provider who wants to work with cannabis clients, you may be a good fit for our service directory. Go to ganjapreneur.com/businesses to create your profile, and start connecting with cannabis entrepreneurs today.

TG Branfalt: Hey, welcome back to the Ganjapreneur.com podcast. I’m TG Branfalt, here with Marc Shepard, co-founder of the New England Cannabis Convention. So I want to talk to you about the NECC. You guys were the first organization to hold these events in the northeast. Why don’t you tell me about it, and what’s the purpose?

Marc Shepard: We’ve actually been doing it for a little while. We came up with the idea in 2014, to sort of create a networking and resource hub for the local cannabis industry. We sort of said, look, medical is here. Rec is going to come, and sort of, our fear, myself and my co founder, Jeff Lawrence, was that with all the successful, existing business models in the other recreational states growing and competing there, when recreational use comes here, how easy is it going to be for them to take their proven models, and just plop them down in New England, and sort of take over the industry and send all the money back out west? Our idea was, how do we get all of the people who are interested in this industry, who are local, in the same room, to network and educate, and learn from each other, and build a framework for a New England-based cannabis economy?

We started with a series of small, local shows in 2015. We did shows in Providence, Rhode Island, Portland, Maine, a couple in Boston, Mass. with the idea of introducing ourselves and the idea, and then circling back to one major show. We did the first one at the Hines Convention Center in Boston this April, and brought in people from all over New England. Obviously, we welcome companies from the outside. We’re not trying to shut out other people, but we just want to give the people locally a chance to compete.

TG Branfalt: Did you have any issues with the Hines Convention Center, specifically as hosts for a cannabis con.?

Marc Shepard: I have to say, we’re very grateful to the Hines. No other convention center in Boston would even accept our show last year. They let us in. When we did sign, recreational use was illegal in Massachusetts. It’s still illegal federally. This is a state-owned facility. We had to sign an agreement saying that there’d be no actual cannabis product onsite. They asked us to sign that again, for our show next April. We signed the contract before the rec ballot passed. We’re sort of in negotiation now about what we can do, for people who have been to cannabis cups, in legal states … The vision of, a gigantic sort of farmer’s market with people sampling and partaking. That’s not going to happen anywhere in Massachusetts. We’ve got to build a model where maybe we host, sort of an event off site, and then for the convention itself, we’ll really just be doing an award show to highlight and celebrate the winners of the cup.

TG Branfalt: What was the turn out like? Was it more than you were expecting? Was it a little less?

Marc Shepard: The one in April, this year, was more. You never know when you haven’t done them. We did smaller shows in 2015 with between 55 and 70 vendors and maybe a couple thousand attendees. Then we did the show in April. We sold out the floor of the Hines. We had about 120 vendors. We had over 4,000 people come in, which certainly beat our projections of what would happen.

TG Branfalt: I was going over the website for the convention, and I saw a very interesting page about a canna-pitch slam. Do you want to elaborate as to what that is?

Marc Shepard: Sure. It’s a stolen idea, for anyone who is familiar with shark tank. It’s something that I had seen at a couple of other conventions, where you encourage young cannabis businesses, or not even born yet cannabis businesses, to submit their business proposal and their investor plan. What we’re going to do, is collect three or four veterans of the cannabis investment community to serve as judges. We’re going to take all the entries, read through them, pick our finalist, and then they’re going to do a live pitch to these people, shark tank style. It’s not going to be the same in that there’s not going to be a massive, onsite investment by these people, but it’s more just the idea of the entertainment of seeing the ideas come out, people competing, and getting hammered by questions in a very interactive type show at the convention.

TG Branfalt: How did you go about working around some of these issues with not being able to have cannabis onsite, and did this impact the expectations, I guess, of the attendees?

Marc Shepard: You certainly field plenty of questions from people asking, can I smoke inside? Can I buy cannabis inside? I understand those questions. I think it’s a little silly when people’s expectations is that they’re going to be able to smoke inside a state building. You can’t smoke a cigarette in there. How are you going to be able to smoke cannabis? Again, at the time, it was illegal.

The people who come to our show we’re really looking at two components. One, people who want to get into the business or are already in the business, and want to network … They don’t care if there’s plants in the show or not. Maybe some people want to demo a product they have and it’s easier to demo with actual cannabis. It’s not very hard to substitute a similar plant. The other half is people who are interested in the medical program, whether they want education for themselves or a loved one, or are trying to understand how to navigate the system, or get involved in that industry. Again, the absence of having an actual cannabis plant, doesn’t really impact that experience.

What we’re missing, and I’m a recreational user myself, I’d love to go to what I would call a pot festival, where there’s buying and selling and comparing. That would be great. I do understand that that’s illegal and it isn’t going to happen in Massachusetts, or anywhere in New England, for a couple of years on. I’m eagerly awaiting when we can do that, but it’s going to be awhile.

TG Branfalt: So, before we go, we’re getting short on time here, could you give me an idea of what was most exciting? What’s the most exciting kind of event or product was, at the last convention, and give our listeners an idea of how they can actually attend the next event?

Marc Shepard: Probably the most well attended and best feedback we got, was we had a programming stage of live demos. The demos went everywhere from cloning, growing, trimming, creating tinctures, making edibles … Every single aspect of home growing and using of cannabis, both for medical and recreational. I think there was a lot of great information there. People got very excited. They met instructors. They were able to get directions on what to do. We’re obviously going to greatly expand that now, for legal home growing and processing. I’m very excited to have a huge expansion of programming for that. The convention is April 22nd and 23rd, 2017. All the information for tickets are on our site, which is NECANN.com, which is N-E-C-A-N-N dot com.

We have very inexpensive tickets for people looking for medical information. They can just go in, pay a small fee to get in, and get access to all of the medical programming. Then there’s a more expensive ticket that gives you access to all of the demos, the business and career advice, and the main keynote speakers, and the full convention experience. It’s still, compared to the national shows that are charging $200, $300, $600 for admission, our ticket prices range between $20 and $70. It’s very affordable for anybody who’s looking to get into this industry.

TG Branfalt: Well Marc, I want to thank you so much for joining me today. It’s really refreshing to get … I’m from New York. I went to college in New York. I’m living in Michigan now, but to see the proliferation of the legal cannabis market, in the northeast, which I adore New England, it’s very refreshing and great that there’s somebody out there who’s already doing conventions and bringing would be cannabusiness owners together.

Marc Shepard: It’s fantastic. It’s a very exciting time in new England for this industry. Everybody I meet, it’s that enthusiasm. You get to be surrounded by smart, driven, motivated people, who are excited to be part of a brand new successful industry that will bring a great economic boom for this region. It’s fantastic to be involved in it.

TG Branfalt: All right. That was Marc Shepard, the co founder of NECANN. I’d like to thank you so much for coming on the Ganjapreneuer.com podcast, and wish you the bet of luck in April.

Marc Shepard: Thank you so much TG. It’s a real pleasure to be here, and I really appreciate the invite. Thank you so much.

TG Branfalt: Thank you, Marc. You can find more episodes of the Ganjapreneur.com podcast, in the podcast section of Ganjapreneur.com, and the Apple iTunes store. On the Ganjapreneur.com website, you’ll find the latest cannabis news and insights and cannabis jobs updated daily, along with transcripts of this podcast. You can also download the Ganjapreneur.com app in iTunes and Google Play. I’ve been your host, TG Branfalt.

End